Healthcare -
Biotechnology - NASDAQ - US
$ 7.37
3.08 %
$ 365 M
Market Cap
-1.47
P/E
RGNX - REVENUE
Revenue RGNX - REGENXBIO Inc.
90.2 M
LAST VALUE
-56.20%
2 YEAR CAGR
-16.21%
5 YEAR CAGR
30.95%
10 YEAR CAGR